etoposide phosphate has been researched along with Blood Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnoud, D; Béné, J; Bruno, B; Odou, P; Simon, N; Vasseur, M | 1 |
| Barbhaiya, RH; Igwemezie, LN; Kaul, S; Srinivas, NR | 1 |
| Alberts, DS; Brooks, DJ | 1 |
| Greco, FA; Hainsworth, JD | 1 |
3 trial(s) available for etoposide phosphate and Blood Diseases
| Article | Year |
|---|---|
A pharmacodynamic evaluation of hematologic toxicity observed with etoposide phosphate in the treatment of cancer patients.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Etoposide; Female; Granulocytes; Hematologic Diseases; Humans; Leukocyte Count; Male; Middle Aged; Models, Biological; Organophosphorus Compounds; Regression Analysis | 1996 |
A phase I study of etoposide phosphate plus paclitaxel.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Drug Administration Schedule; Etoposide; Female; Hematologic Diseases; Humans; Infusions, Intravenous; Male; Middle Aged; Organophosphorus Compounds; Paclitaxel | 1996 |
Clinical studies with etoposide phosphate.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Etoposide; Female; Hematologic Diseases; Humans; Lung Neoplasms; Male; Middle Aged; Organophosphorus Compounds; Remission Induction | 1996 |
1 other study(ies) available for etoposide phosphate and Blood Diseases
| Article | Year |
|---|---|
Should we replace etoposide phosphate by etoposide for allogeneic hematopoetic stem-cell transplantation in children?
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Child; Etoposide; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Organophosphorus Compounds; Prognosis; Transplantation Conditioning; Transplantation, Homologous | 2018 |